Cue Biopharma, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| DIGIANDOMENICO ANTHONY | — | Purchase | 10,000 | $4.49 | $44,900 | 20,000 | Dec 21, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 9,438 | $4.74 | $44,736 | 34,234 | Dec 20, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 400 | $5.00 | $2,000 | 24,796 | Dec 19, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 3,664 | $5.20 | $19,053 | 24,396 | Dec 18, 2018 |
| DIGIANDOMENICO ANTHONY | — | Purchase | 10,000 | $5.48 | $54,800 | 10,000 | Dec 17, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 10,000 | $5.06 | $50,600 | 20,732 | Dec 13, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 3,189 | $5.07 | $16,168 | 10,732 | Dec 12, 2018 |
| MARLETT CHRISTOPHER A | — | Purchase | 7,543 | $4.86 | $36,659 | 7,543 | Dec 11, 2018 |
| Millar Kerri-Ann | VP-Finance | Purchase | 1,000 | $8.48 | $8,480 | 1,000 | Aug 29, 2018 |
| PASSERI DANIEL R | CEO and President | Purchase | 6,000 | $8.09 | $48,540 | 47,600 | Aug 16, 2018 |
| MARLETT CHRISTOPHER A | — | Gift | 1,000 | — | — | 1,016,973 | Jul 10, 2018 |
| PASSERI DANIEL R | CEO and President | Purchase | 1,600 | $11.97 | $19,152 | 41,600 | Jun 29, 2018 |
| Pienta Kenneth | Chief Medical Officer | Purchase | 2,000 | $7.50 | $15,000 | 2,000 | Dec 27, 2017 |